Literature DB >> 28891016

Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: potential pitfalls of a multicentre observational study.

R O Perez1,2,3, A Habr-Gama4,5, G P São Julião4, B B Vailati4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28891016     DOI： 10.1007/s10151-017-1686-9

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  9 in total

1.  Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.

Authors:  Julio Garcia-Aguilar; Oliver S Chow; David D Smith; Jorge E Marcet; Peter A Cataldo; Madhulika G Varma; Anjali S Kumar; Samuel Oommen; Theodore Coutsoftides; Steven R Hunt; Michael J Stamos; Charles A Ternent; Daniel O Herzig; Alessandro Fichera; Blase N Polite; David W Dietz; Sujata Patil; Karin Avila
Journal:  Lancet Oncol       Date:  2015-07-14       Impact factor: 41.316

2.  Is tailoring treatment of rectal cancer the only true benefit of long-course neoadjuvant chemoradiation?

Authors:  Angelita Habr-Gama; Joaquim Gama-Rodrigues; Rodrigo Oliva Perez
Journal:  Dis Colon Rectum       Date:  2013-02       Impact factor: 4.585

3.  Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study.

Authors:  A Barina; A De Paoli; P Delrio; M Guerrieri; A Muratore; F Bianco; D Vespa; C Asteria; E Morpurgo; A Restivo; C Coco; U Pace; C Belluco; C Aschele; S Lonardi; V Valentini; G Mantello; I Maretto; P Del Bianco; A Perin; S Pucciarelli
Journal:  Tech Coloproctol       Date:  2017-07-28       Impact factor: 3.781

4.  Baseline T Classification Predicts Early Tumor Regrowth After Nonoperative Management in Distal Rectal Cancer After Extended Neoadjuvant Chemoradiation and Initial Complete Clinical Response.

Authors:  Angelita Habr-Gama; Guilherme Pagin São Julião; Joaquim Gama-Rodrigues; Bruna Borba Vailati; Cinthia Ortega; Laura Melina Fernandez; Sérgio Eduardo Alonso Araújo; Rodrigo Oliva Perez
Journal:  Dis Colon Rectum       Date:  2017-06       Impact factor: 4.585

5.  Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.

Authors:  Prajnan Das; John M Skibber; Miguel A Rodriguez-Bigas; Barry W Feig; George J Chang; Robert A Wolff; Cathy Eng; Sunil Krishnan; Nora A Janjan; Christopher H Crane
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

6.  Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy: The Impact of Radiation Therapy Dose-escalation and Consolidation Chemotherapy.

Authors:  Angelita Habr-Gama; Guilherme Pagin São Julião; Bruna Borba Vailati; Jorge Sabbaga; Patricia Bailão Aguilar; Laura Melina Fernandez; Sergio Eduardo Alonso Araújo; Rodrigo Oliva Perez
Journal:  Ann Surg       Date:  2019-01       Impact factor: 12.969

7.  Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.

Authors:  Eric Rullier; Philippe Rouanet; Jean-Jacques Tuech; Alain Valverde; Bernard Lelong; Michel Rivoire; Jean-Luc Faucheron; Mehrdad Jafari; Guillaume Portier; Bernard Meunier; Igor Sileznieff; Michel Prudhomme; Frédéric Marchal; Marc Pocard; Denis Pezet; Anne Rullier; Véronique Vendrely; Quentin Denost; Julien Asselineau; Adélaïde Doussau
Journal:  Lancet       Date:  2017-06-07       Impact factor: 79.321

8.  Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy.

Authors:  Ane L Appelt; John Pløen; Ivan R Vogelius; Søren M Bentzen; Anders Jakobsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-03       Impact factor: 7.038

9.  Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.

Authors:  Julio Garcia-Aguilar; Lindsay A Renfro; Oliver S Chow; Qian Shi; Xiomara W Carrero; Patricio B Lynn; Charles R Thomas; Emily Chan; Peter A Cataldo; Jorge E Marcet; David S Medich; Craig S Johnson; Samuel C Oommen; Bruce G Wolff; Alessio Pigazzi; Shane M McNevin; Roger K Pons; Ronald Bleday
Journal:  Lancet Oncol       Date:  2015-10-22       Impact factor: 41.316
  9 in total
  3 in total

1.  Authors' reply to "Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: potential pitfalls of a multicentre observational study".

Authors:  S Pucciarelli; V Valentini; C Aschele; A Barina
Journal:  Tech Coloproctol       Date:  2018-01-15       Impact factor: 3.781

Review 2.  Novelties in treatment of locally advanced rectal cancer.

Authors:  Fabian Grass; Kellie Mathis
Journal:  F1000Res       Date:  2018-11-29

3.  Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis.

Authors:  Guo-Hua Zhao; Li Deng; Dong-Man Ye; Wen-Hui Wang; Yan Yan; Tao Yu
Journal:  World J Surg Oncol       Date:  2020-08-31       Impact factor: 2.754
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.